Richard A. King
Rating: 4.9 of 5
( out of 82 reviews )

Richard A. King, MD

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Dr. Richard King is an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners
    American Board of Internal Medicine (Internal Medicine)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 82 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. King is very kind! He listens to what you have to say and is always willing to give advice or go the extra mile to make sure you get answers.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    He is great to talk with. Explains things so its easy to understand. He explains the next steps you will take and has time for your questions

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    This doctor is for life great experiences how ever patient must always review his or her issues and always need to have be same page as Doctors. If you research it then see Doctor you know getting best care.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    He is very kind and understanding of my worries and fears. He explains each step and symptom so I understand what is happening. I'm very confident in his care....even from a distance he is very involved in my treatment.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Very good doctor. Knowledgable and and was prepared for the visit. Listens very well and thoughtfully answers questions.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    This is one fantastic young doctor. I highly recommend him for your care, you will not regret it.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    He listens carefully. He is obviously very capable and knowledgeable. My case is difficult and it will take some time to see if he is able to come up with a diagnosis (if it's possible!)

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Very professional man that takes the time to help you understand what you need to.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Listened well and asks good questions. I appreciate him treating me respectfully

  • Dr. Richard King is an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Undergraduate Major: Biomedical Engineering; Minor: Mathematics - University of Cincinnati B.S.
    Professional Medical Medicine - Ohio State University College of Medicine M.D.
    Residency Internal Medicine - University of Michigan Health System Resident
    Fellowship Hematology/Oncology - University of Michigan Health System Fellow

    Selected Publications

    Journal Article

    1. Oren L, Khosla S, Murugappan S, King R, Gutmark (2009). Role of subglottal shape in turbulence reduction. The Annals of otology, rhinology, and laryngology, 118(3), 232-40. (Read full publication)
    2. Reid JH, Durant KM, Chen SL, Perissinotti AJ, King R, Khoriaty R, Marini B (2020). Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura. Journal of oncology pharmacy practice, 26(7), 1695-1702. (Read full publication)
    3. Lin Z, King R, Tang V, Myers G, Balbin-Cuesta G, Friedman A, McGee B, Desch K, Ozel AB, Siemieniak D, Reddy P, Emmer B, Khoriaty (2020). The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion. Molecular and cellular biology, 40(23), (Read full publication)
    4. Kim S, Khoriaty R, Li L, McClune M, Kalfa TA, Wu J, Peltier D, Fujiwara H, Sun Y, Oravecz-Wilson K, King RA, Ginsburg D, Reddy (2021). ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity. The Journal of clinical investigation, 131(2), (Read full publication)
    5. King R, Lin Z, Balbin-Cuesta G, Myers G, Friedman A, Zhu G, McGee B, Saunders TL, Kurita R, Nakamura Y, Engel JD, Reddy P, Khoriaty (2021). SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II. Science advances, 7(48), eabj5293. (Read full publication)
    6. King R, Schaefer J, Sahai V, Griffith KA, Sood S (2022). Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter. TH open, 6(3), e221-e229. (Read full publication)

    Review

    1. King R, Gallagher PJ, Khoriaty (2022). The congenital dyserythropoieitic anemias: genetics and pathophysiology. Current opinion in hematology, 29(3), 126-136. (Read full publication)
    2. King RA, Khoriaty (2025). Hereditary disorders of ineffective erythropoiesis. Blood cells, molecules & diseases, 111, 102910. (Read full publication)